Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1

Biochemical and Biophysical Research Communications

Volumn 291, Issue 4, 2002, Pages 908-914

  Liu, Louis X ^a   Lu, Hsienwie ^a   Luo, Yuxia ^a   Date, Taro ^a   Belanger, Adam J ^a   Vincent, Karen A ^a   Akita, Geoffrey Y ^a   Goldberg, Mark ^a   Cheng, Seng H ^a   Gregory, Richard J ^a   Jiang, Canwen ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

HIF; Hypoxia; mRNA stability; Vascular endothelial growth factor

Indexed keywords

ADENOVIRUS VECTOR; HYBRID PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL HYPOXIA; CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPRESSION VECTOR; FETUS; GENE CONSTRUCT; GLIOMA CELL; HALF LIFE TIME; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RAT; TRANSGENE; VASCULAR SMOOTH MUSCLE; WILD TYPE;

EID: 18444364209     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2002.6551     Document Type: Article

References (47)

1. Oxygen sensing and molecular adaptation to hypoxia
2. The hypoxic response: Huffing and HIFing
3. 2, and the 3 PHDs. How animal cells signal hypoxia to the nucleus
4. 2 tension
5. 2-dependent degradation domain via the ubiquitin-proteasome pathway
6. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
7. Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
8. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein
9. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
10. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
11. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
12. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
13. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein
14. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein
15. 2 sensing
16. 2-regulated prolyl hydroxylation
17. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation
18. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
19. Coronary collateral recruitment: Functional significance and relation to rate of vessel closure
20. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
21. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
22. Vascular endothelial growth factor is a secreted angiogenic mitogen
23. Angiogenesis
24. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
25. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
26. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
27. mRNA stability in mammalian cells
28. Hypoxia-induced regulation of mRNA stability
29. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR
30. Identification of a human VPF/VEGF 3′ untranslated region mediating hypoxia-induced mRNA stability
31. Regulation of human vascular endothelial growth factor mRNA stability in hypoxia by heterogeneous nuclear ribonucleoprotein L.
32. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability
33. Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding a HIF-1α/VP16 hybrid transcriptional factor
34. Genome-wide gene expression profiling in human cardiac cells subjected to hypoxia or expressing a constitutively stable hybrid form of HIF-1α
35. Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization
36. Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts
37. Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein
38. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: Implications for models of hypoxia signal transduction
39. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: Key sequence features controlling mRNA deadenylation and decay
40. Post-transcriptional deregulation of myc genes in lung cancer cell lines
41. Cardiac angiogenesis and gene therapy: A strategy for myocardial revascularization
42. Clinical applications of angiogenic growth factors and their inhibitors
43. Endothelial signal integration in vascular assembly
44. Isolation of putative progenitor endothelial cells for angiogenesis
45. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells
46. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
47. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha